CardioConvergence is a peer reviewed, gold open access journal dedicated to uniting the full spectrum of cardiovascular subspecialties on a single platform. We prioritise studies that cross traditional silos—linking innovations such as AI powered imaging, low risk transcatheter valve therapy, remote heart failure monitoring, and cardio oncology survivorship pathways—with the ultimate goal of improving acute and long-term cardiovascular outcomes.

The journal welcomes original investigations, rapid communications, technology validation studies, systematic reviews, health policy analyses and FAIR compliant datasets. Manuscripts are evaluated for scientific rigour, methodological transparency, patient centred impact and readiness for clinical or policy translation. We enforce reporting standards (CONSORT, STROBE AI, PRISMA, etc.) and require open data/code where feasible.